NA Body directs DRAP for performance re-evaluation.

ISLAMABAD -- The Sub-Committee National Assembly Standing Committee on National Health Services, Regulations and Coordination Thursday directed Drug Regulatory Authority of Pakistan (DRAP) to further evaluate its performance and ensure quality of raw materials used for medicines.

The meeting of sub-committee was held here at Parliament House under the Chairmanship of Convener Committee Dr. Nisar Ahmed Cheema.

The committee discussed in details the quality assurance of raw materials and end products, registration of pharmaceutical companies, drugs and pricing of drugs.

The convener expressed concerns...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT